Last reviewed · How we verify

NCT04811300

mCVI® Lighting Conditions Clinical Study

Completed Last updated 19 May 2021
What this trial tests

trial testing There is no intervention in Algorithm Verification in 9 participants. Completed in 15 May 2021.

Timeline
9 April 2021
Primary endpoint
11 April 2021
15 May 2021

Quick facts

Lead sponsorIntelomed, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment9
Start date9 April 2021
Primary completion11 April 2021
Estimated completion15 May 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Intelomed, Inc.

Who can join

Adults 21 to 70, any sex, with Algorithm Verification. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single center prospective clinical study is to verify the algorithm of mCVI® in 4 different lighting conditions to accurately capture pulse rate and respiratory rate in 10 healthy subjects in comparison to commercially-available Masimo pulse oximeter devices. This is a non significant risk device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of There is no intervention

Trials testing the same drug.

Other Intelomed, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04811300.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing